Developing Lung Diagnostic Tests for COVID and Assessing Lung Transplant Donors with Dr. Eric Brouwer SQI Diagnostics

Published: May 26, 2022, 4:10 p.m.

Dr. Eric Brouwer is the Chief Scientific Officer for SQI Diagnostics, which believes that lung health is human health.  Their focus is on the lung and ranges from COVID PCR, antigen, and antibody tests, across the spectrum to assessing lung transplant donors. With demand going up for lung transplants and new protocols for COVID screening of donors, diagnostic tests help better identify good candidates for organ donors.

Eric elaborates, "We're a Canadian-based company, and we have the distribution rights in Canada for a technology that was developed by the US military. The product is called Biomeme, and it's a portable PCR analyzer. So it does very rapid thermocycling that will enable the results to be delivered in just over two hours."

"This is deployed in mines and remote locations, on TV and film crew sets, and so that technology exists. We're using it, and that really makes that testing cycle reduced, so we can get same-morning tests, same-day testing, versus sending it in to a central lab which has the travel time, which has the review time, which has the execution time, that's pushing four to eight, sometimes 24 hours, before those results can get back. So the technology is out there, and it's becoming more widely available."

#SQI #COVID #COVIDTesting #PCRTest #Lungs #LungTransplants #Antibodies #Inflammation #LungDiagnostics #TransplantDiagnostics #PrecisionMedicine

SQIDiagnostics.com

Download the transcript here

SQI